These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36892733)

  • 21. Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
    Chan CH; Chan HY; Chen YC
    Int Clin Psychopharmacol; 2018 May; 33(3):155-162. PubMed ID: 29324468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine Monotherapy as a Treatment for Antipsychotic-Induced Tardive Dyskinesia: A Meta-Analysis.
    Mentzel TQ; van der Snoek R; Lieverse R; Oorschot M; Viechtbauer W; Bloemen O; van Harten PN
    J Clin Psychiatry; 2018 Sep; 79(6):. PubMed ID: 30257080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Earlier Diagnosis of Tardive Dyskinesia.
    Kremens DE
    J Clin Psychiatry; 2019 Dec; 81(1):. PubMed ID: 31846242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference.
    Stacy M; Sajatovic M; Kane JM; Cutler AJ; Liang GS; O'Brien CF; Correll CU
    Mov Disord; 2019 Aug; 34(8):1203-1209. PubMed ID: 31234240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Tardive Dyskinesia in an Electronic Medical Record Study at a Large Community Mental Health Treatment Center.
    North CS; McDonald K; Hunter J; Burruss J
    Prim Care Companion CNS Disord; 2022 Jun; 24(4):. PubMed ID: 35768015
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness: The Curaçao Extrapyramidal Syndromes Study XII.
    Mentzel CL; Bakker PR; van Os J; Drukker M; Matroos GE; Hoek HW; Tijssen MA; van Harten PN
    J Clin Psychiatry; 2017 Mar; 78(3):e279-e285. PubMed ID: 28199071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative Burden of Illness in Veterans With Tardive Dyskinesia and Serious Mental Disorders.
    Caroff SN; Leong SH; Roberts C; Berkowitz RM; Campbell EC
    J Clin Psychopharmacol; 2020; 40(1):38-45. PubMed ID: 31834084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient perspective of tardive dyskinesia: results from a social media listening study.
    Farrar M; Lundt L; Franey E; Yonan C
    BMC Psychiatry; 2021 Feb; 21(1):94. PubMed ID: 33588795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining utility values for patients with tardive dyskinesia.
    Ayyagari R; Goldschmidt D; Zhou M; Ribalov R; Caroff SN; Leo S
    Curr Med Res Opin; 2022 Mar; 38(3):401-407. PubMed ID: 35045768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping World Health Organization Quality of Life-BREF Onto 5-Level EQ-5D in Thai Patients With Chronic Diseases.
    Sakthong P
    Value Health; 2021 Aug; 24(8):1089-1094. PubMed ID: 34372973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, clinical correlates and risk factors associated with Tardive Dyskinesia in Chinese patients with schizophrenia.
    Uludag K; Wang DM; Goodman C; Chen DC; Wang L; Zhang X
    Asian J Psychiatr; 2021 Dec; 66():102877. PubMed ID: 34638091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.
    McEvoy J; Park T; Schilling T; Terasawa E; Ayyagari R; Carroll B
    Curr Med Res Opin; 2019 Jul; 35(7):1205-1214. PubMed ID: 30638073
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder.
    Gardea-Resendez M; Taylor-Desir MJ; Romo-Nava F; Bond D; Vallender EJ; Cuellar-Barboza AB; Prieto ML; Nunez N; Veldic M; Ozerdem A; Singh B; Markota M; Colby CL; Coombes BJ; Biernacka JM; McElroy SL; Frye MA
    J Clin Psychopharmacol; 2022 Mar-Apr 01; 42(2):159-162. PubMed ID: 35230047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.
    Trosch RM; Comella CL; Caroff SN; Ondo WG; Shillington AC; LaChappelle BJ; Hauser RA; Correll CU; Friedman JH
    J Clin Psychiatry; 2024 Jan; 85(1):. PubMed ID: 38270545
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.
    Loughlin AM; Lin N; Abler V; Carroll B
    PLoS One; 2019; 14(6):e0216044. PubMed ID: 31163035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of valbenazine in Japanese patients with tardive dyskinesia: A multicenter, randomized, double-blind, placebo-controlled study (J-KINECT).
    Horiguchi J; Watanabe K; Kondo K; Iwatake A; Sakamoto H; Susuta Y; Masui H; Watanabe Y
    Psychiatry Clin Neurosci; 2022 Nov; 76(11):560-569. PubMed ID: 36114799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment.
    Liang Q; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    J Psychiatr Res; 2022 Jul; 151():181-187. PubMed ID: 35489178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan.
    Shimizu U; Aoki H; Sakagami M; Akazawa K
    Arch Gerontol Geriatr; 2018; 78():96-100. PubMed ID: 29936330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.
    Carbon M; Hsieh CH; Kane JM; Correll CU
    J Clin Psychiatry; 2017 Mar; 78(3):e264-e278. PubMed ID: 28146614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
    Preskorn SH; Macaluso M
    J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.